vs

Side-by-side financial comparison of Aditxt, Inc. (ADTX) and Cyngn Inc. (CYN). Click either name above to swap in a different company.

Cyngn Inc. is the larger business by last-quarter revenue ($68.1K vs $44.3K, roughly 1.5× Aditxt, Inc.). On growth, Cyngn Inc. posted the faster year-over-year revenue change (-77.8% vs -80.0%). Over the past eight quarters, Cyngn Inc.'s revenue compounded faster (251.5% CAGR vs -63.0%).

Aditxt, Inc. is a clinical-stage biotechnology company focused on immunology. It develops targeted therapies to promote immune tolerance for patients with autoimmune diseases and organ transplant recipients, plus immune monitoring technologies. Its main markets are in North America, with expansion efforts underway in other global developed healthcare regions.

Cyngn Inc. is a technology firm specializing in AI-powered autonomous driving solutions for industrial use cases. It develops self-driving software and hardware integration tools for industrial vehicles including forklifts and pallet trucks, serving manufacturing, warehousing, and logistics customers across North America to improve operational efficiency and worksite safety.

ADTX vs CYN — Head-to-Head

Bigger by revenue
CYN
CYN
1.5× larger
CYN
$68.1K
$44.3K
ADTX
Growing faster (revenue YoY)
CYN
CYN
+2.2% gap
CYN
-77.8%
-80.0%
ADTX
Faster 2-yr revenue CAGR
CYN
CYN
Annualised
CYN
251.5%
-63.0%
ADTX

Income Statement — Q2 FY2024 vs Q4 FY2025

Metric
ADTX
ADTX
CYN
CYN
Revenue
$44.3K
$68.1K
Net Profit
$-7.5M
Gross Margin
47.8%
17.5%
Operating Margin
-13497.1%
Net Margin
-17051.3%
Revenue YoY
-80.0%
-77.8%
Net Profit YoY
-32.9%
87.7%
EPS (diluted)
$-1047.17

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ADTX
ADTX
CYN
CYN
Q4 25
$68.1K
Q3 25
$70.0K
Q2 25
$33.7K
Q1 25
$47.2K
Q4 24
$306.4K
Q3 24
$47.6K
Q2 24
$44.3K
$8.7K
Q1 24
$79.7K
$5.5K
Net Profit
ADTX
ADTX
CYN
CYN
Q4 25
Q3 25
$-8.4M
Q2 25
$-5.4M
Q1 25
$-7.6M
Q4 24
$-16.1M
Q3 24
$-5.4M
Q2 24
$-7.5M
$-5.8M
Q1 24
$-14.7M
$-6.0M
Gross Margin
ADTX
ADTX
CYN
CYN
Q4 25
17.5%
Q3 25
27.4%
Q2 25
49.8%
Q1 25
74.9%
Q4 24
18.5%
Q3 24
Q2 24
47.8%
Q1 24
17.4%
Operating Margin
ADTX
ADTX
CYN
CYN
Q4 25
Q3 25
-12028.9%
Q2 25
-16313.4%
Q1 25
-11060.0%
Q4 24
-1808.7%
Q3 24
-11575.7%
Q2 24
-13497.1%
-67076.8%
Q1 24
-14477.5%
-108223.5%
Net Margin
ADTX
ADTX
CYN
CYN
Q4 25
Q3 25
-12059.9%
Q2 25
-16154.6%
Q1 25
-16102.9%
Q4 24
-5261.2%
Q3 24
-11405.9%
Q2 24
-17051.3%
-67154.7%
Q1 24
-18486.1%
-108290.9%
EPS (diluted)
ADTX
ADTX
CYN
CYN
Q4 25
Q3 25
$-1.20
Q2 25
$-2.70
Q1 25
$-6.60
Q4 24
$-1079.39
Q3 24
$-408.30
Q2 24
$-1047.17
$-610.85
Q1 24
$-91439.43
$-422.87

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ADTX
ADTX
CYN
CYN
Cash + ST InvestmentsLiquidity on hand
$91.2K
$34.7M
Total DebtLower is stronger
Stockholders' EquityBook value
$6.6M
$38.8M
Total Assets
$28.4M
$50.1M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ADTX
ADTX
CYN
CYN
Q4 25
$34.7M
Q3 25
$34.9M
Q2 25
$39.2M
Q1 25
$16.3M
Q4 24
$23.6M
Q3 24
$812.8K
Q2 24
$91.2K
$7.0M
Q1 24
$88.7K
$4.8M
Stockholders' Equity
ADTX
ADTX
CYN
CYN
Q4 25
$38.8M
Q3 25
$38.7M
Q2 25
$46.8M
Q1 25
$22.1M
Q4 24
$-1.0M
Q3 24
$6.6M
Q2 24
$6.6M
$9.7M
Q1 24
$9.9M
$8.0M
Total Assets
ADTX
ADTX
CYN
CYN
Q4 25
$50.1M
Q3 25
$49.3M
Q2 25
$56.2M
Q1 25
$24.3M
Q4 24
$30.1M
Q3 24
$8.5M
Q2 24
$28.4M
$11.9M
Q1 24
$28.0M
$9.8M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ADTX
ADTX
CYN
CYN
Operating Cash FlowLast quarter
$-2.3M
$-23.6M
Free Cash FlowOCF − Capex
$-24.8M
FCF MarginFCF / Revenue
-36414.2%
Capex IntensityCapex / Revenue
1806.3%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-42.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ADTX
ADTX
CYN
CYN
Q4 25
$-23.6M
Q3 25
$-4.1M
Q2 25
$-6.3M
Q1 25
$-6.5M
Q4 24
$-3.6M
Q3 24
$-5.3M
Q2 24
$-2.3M
$-4.4M
Q1 24
$-6.0M
$-5.8M
Free Cash Flow
ADTX
ADTX
CYN
CYN
Q4 25
$-24.8M
Q3 25
$-4.6M
Q2 25
$-6.4M
Q1 25
$-6.7M
Q4 24
$-4.0M
Q3 24
$-5.5M
Q2 24
$-4.7M
Q1 24
$-6.1M
FCF Margin
ADTX
ADTX
CYN
CYN
Q4 25
-36414.2%
Q3 25
-6552.1%
Q2 25
-19070.4%
Q1 25
-14191.4%
Q4 24
-1291.7%
Q3 24
-11531.2%
Q2 24
-54799.1%
Q1 24
-109824.6%
Capex Intensity
ADTX
ADTX
CYN
CYN
Q4 25
1806.3%
Q3 25
742.5%
Q2 25
517.1%
Q1 25
378.5%
Q4 24
101.7%
Q3 24
341.4%
Q2 24
4192.3%
Q1 24
3886.1%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons